CS320285A2 - Zpusob vyroby n,3 disubstituovanych 2 oxindol 1 karboxamidu - Google Patents

Zpusob vyroby n,3 disubstituovanych 2 oxindol 1 karboxamidu

Info

Publication number
CS320285A2
CS320285A2 CS853202A CS320285A CS320285A2 CS 320285 A2 CS320285 A2 CS 320285A2 CS 853202 A CS853202 A CS 853202A CS 320285 A CS320285 A CS 320285A CS 320285 A2 CS320285 A2 CS 320285A2
Authority
CS
Czechoslovakia
Prior art keywords
karboxamidu
disubstituovanych
oxindol
zpusob vyroby
vyroby
Prior art date
Application number
CS853202A
Other languages
Czech (cs)
Other versions
CS252828B2 (en
Inventor
Saul Bernard Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to CS861189A priority Critical patent/CS252847B2/en
Publication of CS320285A2 publication Critical patent/CS320285A2/en
Publication of CS252828B2 publication Critical patent/CS252828B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS853202A 1984-05-04 1985-05-04 Method of n,3-disubstituted 2-oxindole-1-carboxamides production CS252828B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS861189A CS252847B2 (en) 1984-05-04 1986-02-20 Method of n,3-disubstituted 2-oxindole-1-carboxyamides production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
CS320285A2 true CS320285A2 (en) 1987-03-12
CS252828B2 CS252828B2 (en) 1987-10-15

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
CS853202A CS252828B2 (en) 1984-05-04 1985-05-04 Method of n,3-disubstituted 2-oxindole-1-carboxamides production

Country Status (25)

Country Link
JP (1) JPS60243068A (en)
KR (1) KR870000497B1 (en)
AR (1) AR241159A1 (en)
BG (2) BG60208B2 (en)
CS (1) CS252828B2 (en)
DD (1) DD232916A5 (en)
EG (1) EG17193A (en)
ES (2) ES8609248A1 (en)
FI (1) FI80016C (en)
HU (1) HU196057B (en)
IE (1) IE851103L (en)
IN (1) IN161509B (en)
MA (1) MA20424A1 (en)
MW (1) MW1685A1 (en)
MX (1) MX5839A (en)
NO (1) NO163132C (en)
OA (1) OA08098A (en)
PL (2) PL145416B1 (en)
PT (1) PT80375B (en)
RO (2) RO94455B (en)
RU (1) RU2017729C1 (en)
SU (1) SU1468413A3 (en)
YU (1) YU44998B (en)
ZA (1) ZA853324B (en)
ZW (1) ZW7885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-substituted-2-oxindole derivatives for the preparation of a pharmaceutical preparation for inhibiting interleukin-1 biosynthesis

Also Published As

Publication number Publication date
AR241159A2 (en) 1991-12-30
ES8707182A1 (en) 1987-07-16
HUT37754A (en) 1986-02-28
NO163132B (en) 1990-01-02
MW1685A1 (en) 1986-09-10
JPS60243068A (en) 1985-12-03
ZA853324B (en) 1986-12-30
RO94455A (en) 1988-06-30
PL253203A1 (en) 1986-06-17
MA20424A1 (en) 1985-12-31
SU1468413A3 (en) 1989-03-23
YU44998B (en) 1991-06-30
RO94455B (en) 1988-07-01
ES551275A0 (en) 1987-07-16
CS252828B2 (en) 1987-10-15
FI851756A0 (en) 1985-05-03
RO91141A (en) 1987-06-30
ZW7885A1 (en) 1985-07-24
PT80375A (en) 1985-05-01
IN161509B (en) 1987-12-19
BG60208B2 (en) 1993-12-30
NO851774L (en) 1985-11-05
YU73085A (en) 1988-04-30
BG60207B2 (en) 1993-12-30
MX5839A (en) 1993-11-01
FI80016C (en) 1990-04-10
PL257892A1 (en) 1986-10-07
DD232916A5 (en) 1986-02-12
ES8609248A1 (en) 1986-07-16
RU2017729C1 (en) 1994-08-15
KR850008154A (en) 1985-12-13
RO91141B (en) 1987-07-03
FI80016B (en) 1989-12-29
KR870000497B1 (en) 1987-03-12
JPH0335315B2 (en) 1991-05-27
PT80375B (en) 1987-09-30
IE851103L (en) 1985-11-04
HU196057B (en) 1988-09-28
AR241159A1 (en) 1991-12-30
PL147508B1 (en) 1989-06-30
OA08098A (en) 1987-03-31
FI851756L (en) 1985-11-05
ES542813A0 (en) 1986-07-16
NO163132C (en) 1990-04-11
EG17193A (en) 1990-08-30
PL145416B1 (en) 1988-09-30

Similar Documents

Publication Publication Date Title
GB2153821B (en) 3-imidazolylmethyl-1,2,3,9-tetrahydro-4h-carbazol-4-one derivatives
CS78585A2 (en) Zpusob vyroby 1,3 disubstituovanych 2 oxindolu
PH22446A (en) 1,2,4-triazolo-carbamate compounds
EP0183975A3 (en) 5,6,7,8-tetrafluoroanthraquinone derivatives
ZA85575B (en) 1,3,2-dioxaborinanes
GB2162175B (en) 1,8-diacyloxy-10-acylanthrones
HK185395A (en) 9,11-Epoxy-21-hydroxypregnane derivatives
ZA851236B (en) 2-arylimidazo 4,5-cpyridines
IL74595A0 (en) 1,2,4-triazacycloalkadiene derivatives
ZA853510B (en) New 2,4-diamino-6-halogeno-5-alkylthio-pyrimidines
GB2156353B (en) 6,6-ethylenedioxy-22r-hydroxy-2r,3s-isopropylidenedioxy-5a-cholest-23-yne
CS320285A2 (en) Zpusob vyroby n,3 disubstituovanych 2 oxindol 1 karboxamidu
CS219684A1 (en) Sposob pripravy 1 2,6 dimetylfenoxy 2 propylaminu
CS779884A1 (en) Substituovane 11 lpiperidinoalkyl p 6,11 dihydrodibenzo lb,e pthiepin 11 karbonitrily
GB8523735D0 (en) 1,2-benzoxathiine derivatives
EP0170822A3 (en) 2,3-dihydrobenzo-4-oxa-thiine
ZA857123B (en) Substituted 1,1-bis-azolyl-butan-2-ones and-ols
CS395284A1 (en) Zpusob vyroby substituovanych benzisothiazolin 3 on 1,1 dioxidu
CS118986A2 (en) Zpusob vyroby n,3 disubstituovanych 2 oxindol 1 karboxamidu
CS493984A1 (en) Stabilizovany vodny injekcni roztok deamino1, karba1, 0 methyltyrosin2 oxytocinu
CS575184A1 (en) Sposob vyroby 1,1 azobisformamidu
CS449684A1 (en) Zpusob rafinace 2,6 xylenolu
CS834384A1 (en) Zpusob vyroby 2,5 dihydroxybenzensulfonanu vapenateho
CS804584A1 (en) Zpusob pripravy oktafluor 1,3 cyklohexadienu
IE842024L (en) 1,6-naphthyridines

Legal Events

Date Code Title Description
MK4A Patent expired

Effective date: 20000504